Evidence map›Paper›PMID 42797413›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Schisandrin B Targets the PPARγ-MAPK Signaling Axis to Ameliorate High-Fat MCD Diet-Induced MASLD in Mice.

Xi-Yuan Feng, Meng Gao, Fei-Long Liu, Ming-Ze Li, Xiao-Li Cui, Meng-Yang Wang, Zhi-Hong Zhang, He Li, Chun-Mei Wang, Jing-Hui Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xi-Yuan FengSchool of Pharmacy, Beihua University, Jilin 132013, China.ORCID 0009-0003-1199-0775
Meng GaoSchool of Pharmacy, Beihua University, Jilin 132013, China.
Fei-Long LiuSchool of Pharmacy, Beihua University, Jilin 132013, China.
Ming-Ze LiSchool of Pharmacy, Beihua University, Jilin 132013, China.
Xiao-Li CuiSchool of Pharmacy, Beihua University, Jilin 132013, China.
Meng-Yang WangSchool of Pharmacy, Beihua University, Jilin 132013, China.
Zhi-Hong ZhangSchool of Pharmacy, Beihua University, Jilin 132013, China.
He LiSchool of Pharmacy, Beihua University, Jilin 132013, China.ORCID 0000-0002-8750-6404
Chun-Mei WangSchool of Pharmacy, Beihua University, Jilin 132013, China.
Jing-Hui SunSchool of Pharmacy, Beihua University, Jilin 132013, China.ORCID 0000-0002-6417-0813

Funding

National Natural Science Foundation of China 82274081
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

fibrosislipid metabolismmetabolic dysfunction-associated steatotic liver diseaseperoxisome proliferator-activated receptor gammaSchisandrin B

Identifiers

PMID42797413
PMCPMC13610241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.